| Bioidentical Hormones
		
			| Topic OverviewBioidentical hormones are made in
		a laboratory. They are based on compounds found in plants (usually soybeans or
		wild yams). After the plant-based hormone is
		processed, its structure is said to be identical to the
		estrogen,
		progesterone, or
		androgen hormone your body makes. (Well-designed
		studies have yet to prove this theory.footnote 1) A compounding
		pharmacist can offer you a custom-made formulation in one of many forms. You might get a capsule, a skin cream or gel, a tablet to dissolve under your tongue,
		a suppository, or a nose spray. Some commonly prescribed estrogens and
		progesterones are bioidenticals, such as Estrace (estradiol). There's a major difference between custom-made formulations and commercial products. Commercial products are
regulated and tested for purity and potency, but compounding pharmacies are not. Just like synthetic hormone therapy, bioidentical hormones
		are prescribed to increase or stabilize a woman's hormone levels.
		This is most often done during perimenopause, when hormone levels change
		unpredictably. It's also done after menopause, when the hormones drop to low levels.
		 The most important fact to remember about taking bioidentical hormones is that the risks are not yet well understood. They may have the same breast cancer, stroke, blood clot, heart disease, and dementia risks that synthetic hormone therapy has.footnote 1ReferencesCitationsNorth American Menopause Society (2012). The 2012 hormone therapy position statement 
of the North American Menopause Society. Menopause, 19(3): 257-271. DOI: 
10.1097/gme.0b013e31824b970a. Accessed April 18, 2016.
CreditsByHealthwise StaffPrimary Medical ReviewerAnne C. Poinier, MD - Internal Medicine
 Martin J. Gabica, MD - Family Medicine
 Kathleen Romito, MD - Family Medicine
 Specialist Medical ReviewerCarla J. Herman, MD, MPH - Geriatric Medicine
Current as ofOctober 13, 2016Current as of:
                October 13, 2016North American Menopause Society (2012). The 2012 hormone therapy position statement 
of the North American Menopause Society. Menopause, 19(3): 257-271. DOI: 
10.1097/gme.0b013e31824b970a. Accessed April 18, 2016. Last modified on: 8 September 2017  |  |